Stockscreener 앱 받기
91.12
4.45%
-4.24
시간 외 거래:
90.00
-1.12
-1.23%
Corcept Therapeutics Inc 주식(CORT)의 최신 뉴스
Corcept Therapeutics Inc (CORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
This Warner Bros Discovery Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga
Wolfe Research downgrades Corcept stock on valuation concerns By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) Lifted Earnings Outlook, Is The Stock Now Overvalued? - Yahoo Finance UK
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly - Yahoo Finance UK
Corcept Therapeutics Inc (CORT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Corcept Therapeutics Inc (CORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CORT|Corcept Therapeutics Inc|Price:95.330|Chg%:-1.330 - TradingKey
Corcept Therapeutics Inc (CORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Corcept Therapeutics Inc (CORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WDC: Western Digital Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Corcept Therapeutics Inc (CORT) Fundamental & Financial Data - Stocktwits
CORT: Corcept Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Corcept Therapeutics And 2 Other Growth Stocks With Significant Insider Ownership - simplywall.st
Corcept Therapeutics to announce Q2 results on July 29 - scanx.trade
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call - Yahoo Finance
Corcept Therapeutics stock hits 52-week high at 95.18 USD By Investing.com - Investing.com Canada
Trump Disclosure Shows Corcept Buy Before FDA Approval - Moomoo
CORT Stock Skyrockets 35% After Early FDA Nod For Ovarian Cancer Drug - Stocktwits
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Corcept Therapeutics(CORT.US) Officer Sells US$3.51 Million in Common Stock - Moomoo
Corcept Therapeutics CFO Mokari sells $3.5m in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics CFO Mokari sells $3.5m in shares - Investing.com
Corcept Therapeutics director Wilson sells $882,985 in common stock By Investing.com - Investing.com UK
Form 4 Corcept Therapeutics Incorporated For: 17 July By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) director logs 10,000-share indirect sale under 10b5-1 plan - Stock Titan
Corcept Therapeutics (CORT) CFO sells 40,000 shares and exercises options - Stock Titan
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook - Yahoo Finance
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook - The Motley Fool
Corcept Therapeutics Inc (NASDAQ:CORT) Shows Strong Growth Fundamentals and Technical Breakout Setup - ChartMill
CORT Stock Hits Highest Levels In 2026 – Cushing’s Syndrome Drug NDA Resubmission Extends 5-Session Rally - Stocktwits
Fed. Circ. Won't Rethink Corcept Patent Loss In Teva Case - Law360
Corcept Therapeutics: Recent Relacorilant Rejection Aside, A Good News Story For Investors - Seeking Alpha
Corcept Therapeutics : CORT - 24/7 Wall St.
CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Form 4 Corcept Therapeutics Incorporated For: 8 July By Investing.com - Investing.com Nigeria
Corcept (NASDAQ: CORT) CBO reports 600-share stock gift and holdings - Stock Titan
Corcept Therapeutics CDO William Guyer sells $1.86m in stock - Investing.com
Corcept Therapeutics CDO William Guyer sells $1.86m in stock By Investing.com - Investing.com India
Insider at Corcept (NASDAQ: CORT) sells shares after option exercise - Stock Titan
Form 144 CORCEPT THERAPEUTICS INC For: 7 July By Investing.com - Investing.com Nigeria
William Guyer to sell 20,000 CORT shares (NASDAQ: CORT) via option exercise - Stock Titan
Corcept Therapeutics highlights its endocrine focus as investors watch CORT stock - AD HOC NEWS
CORT News | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill
Corcept (CORT) executive sells 25K shares after exercising options - Stock Titan
CORTCorcept Therapeutics Inc Options - Finviz
Corcept Therapeutics stock hits 52-week high at 91.1 USD By Investing.com - Investing.com Canada
Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report - Sahm
Price to sales forward of Corcept Therapeutics Incorporated – NASDAQ:CORT - TradingView
1.97%
0.83%
자본화:
|
볼륨(24시간):